This Week in Addiction Medicine from ASAM
Health & Fitness:Medicine
Buprenorphine Dispensing Among Youth Aged ≤19 Years in the United States: 2015–2020
Pediatrics
Opioid related overdose among adolescents and young adults in the United States is rising. Medications for opioid use disorder (MOUD), including buprenorphine, can reduce the risk of overdose; however, they are underutilized. Given rates of opioid use disorder (OUD) among youth, these findings suggest that many young people who could benefit from MOUD are not receiving it. Pediatricians could play a role in expanding access to MOUD for this high-risk population. Efforts to expand access to MOUD for adolescents could include improving pediatrician training in OUD treatment and encouraging all clinicians who care for adolescents and young adults to prescribe buprenorphine for MOUD.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
Create your
podcast in
minutes
It is Free